2
Digital IVUS catheter Vision PV .014P RX Designed for peripheral use with greater pushability The Visions PV .014P RX has a 55% stiffer shaft than Eagle Eye Platinum and PV .014P to facilitate greater pushability while preserving the equivalent level of trackability. 1 See clearly. Treat optimally. IVUS provides detailed and accurate assessment of: • Lumen size • Vessel size • Plaque morphology • Key anatomical landmarks By providing detailed and accurate measurements of lumen and vessel size, plaque area and the location of key anatomical landmarks, Philips intravascular ultrasound (IVUS) is a valuable tool in the assessment of peripheral artery disease (PAD). 2,3,4,5,6,7

Designed for peripheral use with greater pushability · impact on in-hospital outcomes from the nationwide inpatient sample (2006 2011). J Endovasc Ther 2016;23(1):65-75. 8. Kumakura

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Designed for peripheral use with greater pushability · impact on in-hospital outcomes from the nationwide inpatient sample (2006 2011). J Endovasc Ther 2016;23(1):65-75. 8. Kumakura

Digital IVUS catheter

Vision PV .014P RX

Designed for peripheral use with greater pushabilityThe Visions PV .014P RX has a 55% stiffer shaft than Eagle Eye Platinum and PV .014P to facilitate greater pushability while preserving the equivalent level of trackability.1

See clearly. Treat optimally.

IVUS provides detailed and accurate assessment of:• Lumen size• Vessel size• Plaque morphology• Key anatomical landmarks

By providing detailed and accurate measurements of lumen and vessel size, plaque area and the location of key anatomical landmarks, Philips intravascular ultrasound (IVUS) is a valuable tool in the assessment of peripheral artery disease (PAD).2,3,4,5,6,7

Page 2: Designed for peripheral use with greater pushability · impact on in-hospital outcomes from the nationwide inpatient sample (2006 2011). J Endovasc Ther 2016;23(1):65-75. 8. Kumakura

3.5783.563

2.296

4

3.5

03

2.5

2

1.5

1

0.5

00 0

1. N=15 Data on File at Philips Corporation.

2. Kashyap VS, Pavkov ML, Bishop PD, Nassoiy SP, Eagleton MJ, Clair DG, Ouriel K. Angiography underestimates peripheral atherosclerosis: lumenography revisited. J Endovasc Ther 2008;15(1):117-25.

3. Iida O, Takahara M, Soga Y, Suzuki K, Hirano K, Kawasaki D, Shintani Y, Suematsu N, Yamaoka T, Nanto S, Uematsu M. Efficacy of intravascular ultrasound in femoropopliteal stenting for peripheral artery disease with TASC II class A to C lesions. J Endovasc Ther 2014;21(4):485-92.

4. Hitchner E, Zayed M, Varu V, Lee G, Aalami O, Zhou W. A prospective evaluation of using IVUS during percutaneous superficial femoral artery interventions. Ann Vasc Surg 2015;29(1):28-33.

5. Lee JT, Fang TD, White RA. Application of intravascular ultrasound in the treatment of peripheral occlusive disease. Semin Vasc Surg 2006;19(3):139-44.

6. Arthurs ZM, Bishop PD, Feiten LE, Eagleton MJ, Clair DG, Kashyap VS. Evaluation of peripheral atherosclerosis: a comparative analysis of angiography and intravascular ultrasound imaging. J Vasc Surg 2010;51(4):933-8.

7. Panaich SS, Arora S, Patel N, Patel NJ, Savani C, Patel A, Thakkar B, Singh V, Patel S, Patel N, Agnihotri K, Bhatt P, Deshmukh A, Gupta V, Attaran RR, Mena CI, Grines CL, Cleman M, Forrest JK, Badheka AO. Intravascular ultrasound in lower extremity peripheral vascular interventions: variation in utilization and impact on in-hospital outcomes from the nationwide inpatient sample (2006 2011). J Endovasc Ther 2016;23(1):65-75.

8. Kumakura H, Kanai H, Araki Y, Hojo Y, Iwasaki T, Ichikawa S. Fifteen-year patency and life expectancy after primary stenting guided by intravascular ultrasound for iliac artery lesions in peripheral arterial disease. JACC Cardiovasc Interv 2015;8(14):1893-901.

When comparing the stiffness of the Visions PV .014P RX to that of the Eagle Eye Platinum control and the Visions PV .018, the data demonstrated that Visions PV .014P RX is 55% stiffer than the Eagle Eye Platinum and is statistically equivalent to that of Visions PV .018.1

Average compression force Visions PV .014P RX % stiffness to control and Visions PV .018

Visions PV .014P RXVisions PV .018Eagle Eye Platinum control

Visions PV .014P RXVisions PV .018Average Eagle Eye Platinum control

Ordering information and technical specificationVisions PV .014P RX digital IVUS catheter 014R

PIM connector

Brachial and femoralshaft markers

Guide wire exit port≤ 0.014" (0.36 mm)

Transducer3.5 F

Tapered tipO.D. 0.019”

150 cm

3.3 F

100 cm

24 cm hydrophilic coating

©2019 Koninklijke Philips N.V. All rights reserved. Approved for external distribution. D041641-01 012019

Philips3721 Valley Centre Drive, Suite 500San Diego, CA 92130 USAwww.philips.com/IGTdevices

Average compression force (Ibf) % Stiffness of control % Stiffness of PV .018

99.6%

155.2% 155.8%

64.2%

More force is required to buckle PV .014P RX

Min sheath: 5FMin guide catheter: 5F (I.D. ≥ .056”)